Thyroid function in end stage renal disease and effects of frequent hemodialysis

Joan C. Lo, Gerald J. Beck, George Kaysen, Christopher T. Chan, Alan S. Kliger, Michael V. Rocco, Minwei Li, Glenn M. Chertow

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Introduction: End-stage renal disease (ESRD) is associated with perturbations in thyroid hormone concentrations and an increased prevalence of hypothyroidism. Few studies have examined the effects of hemodialysis dose or frequency on endogenous thyroid function. Methods: Within the Frequent Hemodialysis Network (FHN) trials, we examined the prevalence of hypothyroidism in patients with ESRD. Among those with endogenous thyroid function (without overt hyper/hypothyroidism or thyroid hormone supplementation), we examined the association of thyroid hormone concentration with multiple parameters of self-reported health status, and physical and cognitive performance, and the effects of hemodialysis frequency on serum thyroid stimulating hormone (TSH), free thyroxine (FT4), and free tri-iodothyronine (FT3) levels. Conventional thrice-weekly hemodialysis was compared to in-center (6 d/wk) hemodialysis (Daily Trial) and Nocturnal (6 nights/wk) home hemodialysis (Nocturnal Trial) over 12 months. Findings: Among 226 FHN Trial participants, the prevalence of hypothyroidism was 11% based on thyroid hormone treatment and/or serum TSH ≥8 mIU/mL. Among the remaining 195 participants (147 Daily, 48 Nocturnal) with endogenous thyroid function, TSH concentrations were modestly (directly) correlated with age (r=0.16, P=0.03) but not dialysis vintage. Circulating thyroid hormone levels were not associated with parameters of health status or physical and cognitive performance. Furthermore, frequent in-center and nocturnal hemodialysis did not significantly change (baseline to month 12) TSH, FT4, or FT3 concentrations in patients with endogenous thyroid function. Discussion: Among patients receiving hemodialysis without overt hyper/hypothyroidism or thyroid hormone treatment, thyroid indices were not associated with multiple measures of health status and were not significantly altered with increased dialysis frequency.

Original languageEnglish (US)
JournalHemodialysis International
DOIs
StateAccepted/In press - 2017

Fingerprint

Chronic Kidney Failure
Renal Dialysis
Thyroid Gland
Thyroid Hormones
Hypothyroidism
Thyrotropin
Health Status
Dialysis
Home Hemodialysis
Serum
Thyroxine
Therapeutics

Keywords

  • Daily dialysis
  • End-stage renal disease
  • Hypothyroidism
  • Nocturnal dialysis
  • Thyroid

ASJC Scopus subject areas

  • Hematology
  • Nephrology

Cite this

Lo, J. C., Beck, G. J., Kaysen, G., Chan, C. T., Kliger, A. S., Rocco, M. V., ... Chertow, G. M. (Accepted/In press). Thyroid function in end stage renal disease and effects of frequent hemodialysis. Hemodialysis International. https://doi.org/10.1111/hdi.12527

Thyroid function in end stage renal disease and effects of frequent hemodialysis. / Lo, Joan C.; Beck, Gerald J.; Kaysen, George; Chan, Christopher T.; Kliger, Alan S.; Rocco, Michael V.; Li, Minwei; Chertow, Glenn M.

In: Hemodialysis International, 2017.

Research output: Contribution to journalArticle

Lo, Joan C. ; Beck, Gerald J. ; Kaysen, George ; Chan, Christopher T. ; Kliger, Alan S. ; Rocco, Michael V. ; Li, Minwei ; Chertow, Glenn M. / Thyroid function in end stage renal disease and effects of frequent hemodialysis. In: Hemodialysis International. 2017.
@article{f061ab43c90d468c8885ca8622e88a52,
title = "Thyroid function in end stage renal disease and effects of frequent hemodialysis",
abstract = "Introduction: End-stage renal disease (ESRD) is associated with perturbations in thyroid hormone concentrations and an increased prevalence of hypothyroidism. Few studies have examined the effects of hemodialysis dose or frequency on endogenous thyroid function. Methods: Within the Frequent Hemodialysis Network (FHN) trials, we examined the prevalence of hypothyroidism in patients with ESRD. Among those with endogenous thyroid function (without overt hyper/hypothyroidism or thyroid hormone supplementation), we examined the association of thyroid hormone concentration with multiple parameters of self-reported health status, and physical and cognitive performance, and the effects of hemodialysis frequency on serum thyroid stimulating hormone (TSH), free thyroxine (FT4), and free tri-iodothyronine (FT3) levels. Conventional thrice-weekly hemodialysis was compared to in-center (6 d/wk) hemodialysis (Daily Trial) and Nocturnal (6 nights/wk) home hemodialysis (Nocturnal Trial) over 12 months. Findings: Among 226 FHN Trial participants, the prevalence of hypothyroidism was 11{\%} based on thyroid hormone treatment and/or serum TSH ≥8 mIU/mL. Among the remaining 195 participants (147 Daily, 48 Nocturnal) with endogenous thyroid function, TSH concentrations were modestly (directly) correlated with age (r=0.16, P=0.03) but not dialysis vintage. Circulating thyroid hormone levels were not associated with parameters of health status or physical and cognitive performance. Furthermore, frequent in-center and nocturnal hemodialysis did not significantly change (baseline to month 12) TSH, FT4, or FT3 concentrations in patients with endogenous thyroid function. Discussion: Among patients receiving hemodialysis without overt hyper/hypothyroidism or thyroid hormone treatment, thyroid indices were not associated with multiple measures of health status and were not significantly altered with increased dialysis frequency.",
keywords = "Daily dialysis, End-stage renal disease, Hypothyroidism, Nocturnal dialysis, Thyroid",
author = "Lo, {Joan C.} and Beck, {Gerald J.} and George Kaysen and Chan, {Christopher T.} and Kliger, {Alan S.} and Rocco, {Michael V.} and Minwei Li and Chertow, {Glenn M.}",
year = "2017",
doi = "10.1111/hdi.12527",
language = "English (US)",
journal = "Hemodialysis International",
issn = "1492-7535",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Thyroid function in end stage renal disease and effects of frequent hemodialysis

AU - Lo, Joan C.

AU - Beck, Gerald J.

AU - Kaysen, George

AU - Chan, Christopher T.

AU - Kliger, Alan S.

AU - Rocco, Michael V.

AU - Li, Minwei

AU - Chertow, Glenn M.

PY - 2017

Y1 - 2017

N2 - Introduction: End-stage renal disease (ESRD) is associated with perturbations in thyroid hormone concentrations and an increased prevalence of hypothyroidism. Few studies have examined the effects of hemodialysis dose or frequency on endogenous thyroid function. Methods: Within the Frequent Hemodialysis Network (FHN) trials, we examined the prevalence of hypothyroidism in patients with ESRD. Among those with endogenous thyroid function (without overt hyper/hypothyroidism or thyroid hormone supplementation), we examined the association of thyroid hormone concentration with multiple parameters of self-reported health status, and physical and cognitive performance, and the effects of hemodialysis frequency on serum thyroid stimulating hormone (TSH), free thyroxine (FT4), and free tri-iodothyronine (FT3) levels. Conventional thrice-weekly hemodialysis was compared to in-center (6 d/wk) hemodialysis (Daily Trial) and Nocturnal (6 nights/wk) home hemodialysis (Nocturnal Trial) over 12 months. Findings: Among 226 FHN Trial participants, the prevalence of hypothyroidism was 11% based on thyroid hormone treatment and/or serum TSH ≥8 mIU/mL. Among the remaining 195 participants (147 Daily, 48 Nocturnal) with endogenous thyroid function, TSH concentrations were modestly (directly) correlated with age (r=0.16, P=0.03) but not dialysis vintage. Circulating thyroid hormone levels were not associated with parameters of health status or physical and cognitive performance. Furthermore, frequent in-center and nocturnal hemodialysis did not significantly change (baseline to month 12) TSH, FT4, or FT3 concentrations in patients with endogenous thyroid function. Discussion: Among patients receiving hemodialysis without overt hyper/hypothyroidism or thyroid hormone treatment, thyroid indices were not associated with multiple measures of health status and were not significantly altered with increased dialysis frequency.

AB - Introduction: End-stage renal disease (ESRD) is associated with perturbations in thyroid hormone concentrations and an increased prevalence of hypothyroidism. Few studies have examined the effects of hemodialysis dose or frequency on endogenous thyroid function. Methods: Within the Frequent Hemodialysis Network (FHN) trials, we examined the prevalence of hypothyroidism in patients with ESRD. Among those with endogenous thyroid function (without overt hyper/hypothyroidism or thyroid hormone supplementation), we examined the association of thyroid hormone concentration with multiple parameters of self-reported health status, and physical and cognitive performance, and the effects of hemodialysis frequency on serum thyroid stimulating hormone (TSH), free thyroxine (FT4), and free tri-iodothyronine (FT3) levels. Conventional thrice-weekly hemodialysis was compared to in-center (6 d/wk) hemodialysis (Daily Trial) and Nocturnal (6 nights/wk) home hemodialysis (Nocturnal Trial) over 12 months. Findings: Among 226 FHN Trial participants, the prevalence of hypothyroidism was 11% based on thyroid hormone treatment and/or serum TSH ≥8 mIU/mL. Among the remaining 195 participants (147 Daily, 48 Nocturnal) with endogenous thyroid function, TSH concentrations were modestly (directly) correlated with age (r=0.16, P=0.03) but not dialysis vintage. Circulating thyroid hormone levels were not associated with parameters of health status or physical and cognitive performance. Furthermore, frequent in-center and nocturnal hemodialysis did not significantly change (baseline to month 12) TSH, FT4, or FT3 concentrations in patients with endogenous thyroid function. Discussion: Among patients receiving hemodialysis without overt hyper/hypothyroidism or thyroid hormone treatment, thyroid indices were not associated with multiple measures of health status and were not significantly altered with increased dialysis frequency.

KW - Daily dialysis

KW - End-stage renal disease

KW - Hypothyroidism

KW - Nocturnal dialysis

KW - Thyroid

UR - http://www.scopus.com/inward/record.url?scp=85015288932&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015288932&partnerID=8YFLogxK

U2 - 10.1111/hdi.12527

DO - 10.1111/hdi.12527

M3 - Article

C2 - 28301073

AN - SCOPUS:85015288932

JO - Hemodialysis International

JF - Hemodialysis International

SN - 1492-7535

ER -